Back to the Top
Plan to attend
Come to Nurnberg and participate in the
World Conference on Dosing of Antiinfectives
“Dosing the Magic Bullets”
Honouring Paul Ehrlich, the “Founder of Chemotherapy”
September 9-11, 2004, Nürnberg, Germany
www.ehrlich2004.org
The Conference
This conference will gather world leaders in the field, like G.L.
Drusano
( Co- Chairman ), L.Z. Benet, Nick Holford, H. Derendorf, J. Mouton and
many
others that are PharmPK members will speak.Fifteen German and
international
organisations like ISAP (International Society of Antiinfective
Pharmacology), ISC International Society of Chemotherapy, ASM (American
Society of Microbiology),FESCI (Federation of European Societies of
Chemotherapy and Infection), 7 Prestigious German Societies and the
Paul-Ehrlich-Institute, GSP-Biomedical Institute and
Robert-Koch-Institute
and others sponsor the conference.
The topics are best viewed on the conference homepage
www.ehrlich2004.org
Present a poster and participate in the competetion for the Magic Bullet
Poster Award
A very special conference with first class science, history of
chemotherapy
and Paul Ehrlich and a warm and friendly atmosphere in one of Germany's
most
enchanting mideval cities.
Honouring Paul Ehrlich - the founder of Chemotherapy
Next year Paul Ehrlich's 150 th birthday will be on March 14th, 2004.The
work of Paul Ehrlich in the infectious diseases field though lead to the
first antibiotic ever developed by systematic research and the
anti-syphilitic agent called Salvarsan ( called “606” in laboratory
jargon,
since it was found among several hundred compounds; the INN name is
“arsphenamine” ). Salvarsan lead to great challenges to its appropriate
dosing, challenges that Ehrlich met with brilliant published fundamental
work that still applies today. Ehrlich used to call his agents “Magic
Bullets” and his whole life was in search of such a “Magic Bullet” that
arsphenamine ( Salvarsan ) came close, at least for him and his times.
He
also introduced the concept of a “ Therapia magna sterilisans” with
earlier
dyes like methylene blue, trypan red and “his” Salvarsan ( turned out
to be
yellow, but was not planned as a dye ) where he attempted to eradicate
the
pathogen with a single dose. See the logo of the conference for
explanations.
Special rates of early registration apply.Registration starts December
1st,
2003.
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)